Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R8SY
|
|||
| Former ID |
DIB007931
|
|||
| Drug Name |
Limtop
|
|||
| Synonyms |
Topical formulation (actinic keratosis/genital warts/basal cell cancer), Moberg Derma
Click to Show/Hide
|
|||
| Indication | Keratosis [ICD-11: ED56; ICD-10: L57.0] | Phase 2 | [1] | |
| Company |
Moberg Derma AB
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01611480) Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.